End-of-day quote
Shanghai S.E.
06:00:00 2024-05-27 pm EDT
|
5-day change
|
1st Jan Change
|
30.9
CNY
|
+3.90%
|
|
+12.04%
|
-7.21%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
10,208
|
18,166
|
30,049
|
18,378
|
19,974
|
18,535
|
-
|
-
|
Enterprise Value (EV)
1 |
10,208
|
18,166
|
30,049
|
18,378
|
19,974
|
18,535
|
18,535
|
18,535
|
P/E ratio
|
31.1
x
|
44.3
x
|
91.5
x
|
62.9
x
|
49
x
|
35.4
x
|
28.9
x
|
24.5
x
|
Yield
|
-
|
-
|
0.18%
|
0.26%
|
1.77%
|
0.45%
|
0.52%
|
0.65%
|
Capitalization / Revenue
|
4.62
x
|
8.88
x
|
13
x
|
7.35
x
|
6.79
x
|
5.03
x
|
4.26
x
|
3.64
x
|
EV / Revenue
|
4.62
x
|
8.88
x
|
13
x
|
7.35
x
|
6.79
x
|
5.03
x
|
4.26
x
|
3.64
x
|
EV / EBITDA
|
23.7
x
|
34.2
x
|
-
|
-
|
35.2
x
|
28.1
x
|
23.5
x
|
19.5
x
|
EV / FCF
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
4.54
x
|
7.42
x
|
11
x
|
6.15
x
|
5.96
x
|
5.04
x
|
4.5
x
|
4.07
x
|
Nbr of stocks (in thousands)
|
585,988
|
585,988
|
597,152
|
596,121
|
599,831
|
599,832
|
-
|
-
|
Reference price
2 |
17.42
|
31.00
|
50.32
|
30.83
|
33.30
|
30.90
|
30.90
|
30.90
|
Announcement Date
|
4/28/20
|
4/15/21
|
4/14/22
|
4/11/23
|
4/24/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
2,208
|
2,046
|
2,308
|
2,500
|
2,944
|
3,683
|
4,355
|
5,085
|
EBITDA
1 |
431.5
|
530.7
|
-
|
-
|
566.9
|
659
|
787.5
|
948.5
|
EBIT
1 |
364.2
|
468.9
|
333.7
|
302.1
|
427.4
|
511.8
|
644
|
794.7
|
Operating Margin
|
16.49%
|
22.92%
|
14.46%
|
12.08%
|
14.52%
|
13.89%
|
14.79%
|
15.63%
|
Earnings before Tax (EBT)
1 |
378.1
|
467.1
|
334.8
|
305.7
|
427
|
530.5
|
621.8
|
798
|
Net income
1 |
330.6
|
410.5
|
326.6
|
298.2
|
406.6
|
521.8
|
640.7
|
756.7
|
Net margin
|
14.97%
|
20.06%
|
14.15%
|
11.93%
|
13.81%
|
14.17%
|
14.71%
|
14.88%
|
EPS
2 |
0.5600
|
0.7000
|
0.5500
|
0.4900
|
0.6800
|
0.8720
|
1.070
|
1.260
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
-
|
-
|
0.0900
|
0.0800
|
0.5900
|
0.1400
|
0.1600
|
0.2000
|
Announcement Date
|
4/28/20
|
4/15/21
|
4/14/22
|
4/11/23
|
4/24/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
15.1%
|
17.5%
|
12.8%
|
10.3%
|
12.6%
|
13.9%
|
15.2%
|
16.7%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
6.18%
|
4.64%
|
-
|
6.47%
|
7.6%
|
8.78%
|
Assets
1 |
-
|
-
|
5,283
|
6,421
|
-
|
8,071
|
8,435
|
8,618
|
Book Value Per Share
2 |
3.840
|
4.180
|
4.570
|
5.010
|
5.590
|
6.130
|
6.870
|
7.600
|
Cash Flow per Share
2 |
0.7100
|
0.3500
|
-
|
0.1700
|
0.3100
|
0.8800
|
0.7800
|
1.000
|
Capex
1 |
71
|
80.4
|
-
|
344
|
141
|
126
|
137
|
161
|
Capex / Sales
|
3.21%
|
3.93%
|
-
|
13.77%
|
4.79%
|
3.42%
|
3.15%
|
3.17%
|
Announcement Date
|
4/28/20
|
4/15/21
|
4/14/22
|
4/11/23
|
4/24/24
|
-
|
-
|
-
|
Last Close Price
30.9
CNY Average target price
35
CNY Spread / Average Target +13.27% Consensus |
1st Jan change
|
Capi.
|
---|
| -7.21% | 2.46B | | +0.88% | 50B | | +21.10% | 42.94B | | +26.15% | 27.25B | | +9.54% | 19.34B | | -2.65% | 16.7B | | +7.54% | 16.1B | | -25.63% | 15.65B | | -11.57% | 15B | | -17.62% | 14.12B |
Other Specialty Chemicals
|